Digbi Health Announces Appointment of Imran Junaid, MD, as Chief Medical Officer
The appointment advances Digbi's integration of genetics and microbiome science with conventional care protocols, and a more integrated role with health plans and health systems.
MOUNTAIN VIEW, Calif., January 23, 2020 /Digbi Newswire/ -- Demonstrating a continued commitment to building a world-class medical affairs leadership team, Digbi Health today announced the appointment of Dr. Imran Junaid, MD, as Chief Medical Officer. The appointment drives the company toward integrating proven, medically effective genetics and microbiome science with conventional care protocols to tackle obesity and associated inflammatory comorbidities, and toward a more integrated role with health plans and health systems.
Background
After completing his training at UCLA, Dr. Junaid helped launch and served as Medical Director of the Medical Weight Management program at Kaiser Permanente. As Executive Medical Director of Jiva Health, he leads a multidisciplinary integrative medical practice focused on precision preventative care for allergy, diabetes and obesity.
In his words
Throughout my career, I have strived to provide specific individualized recommendations to help my patients gain health and reduce disease burden. For too long, we have practiced medicine with one arm tied behind our backs. With genetic and gut microbiome advancements that enable Digbi's platform, we are finally empowered to provide personalized targeted health interventions and fight back the tsunami of obesity-related chronic ailments that degrade the health of our patients. I'm delighted to be part of the team that is at the forefront of combining data science, behavior enablement and traditional care with proven DNA and gut microbiome science to prevent and reverse obesity.
— Imran Junaid, MD, Chief Medical Officer, Digbi Health
Originally distributed via PR Newswire.
About Digbi Health
Digbi Health is the precision biology care company unifying metabolic and inflammatory care — including obesity, cardiometabolic, gastrointestinal, and inflammatory disorders. These illnesses share a root cause: a mismatch between an individual's biology and the one-size-fits-all lifestyle guidance they've been given. Digbi combines the gut microbiome, genetics, advanced blood biomarkers, and continuous digital health data to build a unique biological profile for each individual and identify what is driving their disease. AI then personalizes lifestyle treatment and, when needed, clinical treatment, delivered through the first precision-biology AI-orchestrated national telehealth platform. Through Digbi Labs, we invest in our vision of making chronic illness optional and advancing healthspan — partnering with leading universities, pharmaceutical companies, and scientific and clinical laboratories, running distributed human trials and publishing peer-reviewed research on genetics, the gut microbiome, and the use of AI to deliver care that is safe, cost-effective, and accessible. Digbi's healthcare cost reduction is documented in multiple peer-reviewed actuarial claims studies. Digbi is accessible to 30 million individuals through more than 300 employers and health plans.
SOURCE Digbi Health
- Leadership
- Medical Affairs
- Obesity
- Genetics
- Gut Microbiome